(Q43848444)

27 November 2017

title

Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas (English)

1 reference

27 November 2017

1 reference

10

Mari Mino-Kenudson

1 reference

27 November 2017

4

Kristin Bergethon

1 reference

27 November 2017

6

Dora Dias-Santagata

1 reference

27 November 2017

9

A John Iafrate

1 reference

27 November 2017

Michiya Nishino

1

1 reference

27 November 2017

Veronica E Klepeis

2

1 reference

27 November 2017

Beow Y Yeap

3

1 reference

27 November 2017

Vicente Morales-Oyarvide

5

1 reference

27 November 2017

Yukako Yagi

7

1 reference

27 November 2017

Eugene J Mark

8

1 reference

27 November 2017

publication date

29 June 2012

1 reference

27 November 2017

1 reference

27 November 2017

volume

25

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

1462-1472

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

27 November 2017

1 reference

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Comprehensive histologic analysis of ALK-rearranged lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Prognostic significance of grading in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

7 January 2021

Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

7 January 2021

Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

7 January 2021

A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.109

7 January 2021

10.1038/MODPATHOL.2012.109

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1046189437

0 references

1 reference